Long term survivors and immune biomarker analysis of Phase IIa, randomized study of GVAX pancreas and crs-207 immunotherapy in patients with metastatic pancreatic cancer. Issue 2 (December 2015) - Nair, Nitya; Lemmens, Ed; Enstrom, Amanda; Chen, Shih-Yu; Chang, Serena; Le, Dung; Jaffee, Elizabeth; Maecker, Holden; Murphy, Aimee; Brockstedt, Dirk; Whiting, Chan